Scientists exchanged and discussed the successful anti-epidemic experience and strategies for coping with Omicron mutations in Australia, Japan, the United Kingdom and other countries.
The COVID-19 pandemic of the past two years has exacerbated existing challenges and brought new requirements and opportunities, such as accelerating opportunities to improve the health sector and expanding the ability of more people around the world to access health care.
Experience in multiple countries
Recently, an international conference on COVID-19 was held in Baimai Hospital, and reports and experience sharing of leading experts from all over the world and Vietnam participated in the conference.
The rapporteurs and scientists exchanged, discussed and learned from their international counterparts, especially the successful anti-epidemic experiences and strategies of Australia, Japan and the United Kingdom. Response to Omicron variants.
[The Ministry of Health continues to notify Pfizer to extend the shelf life of vaccines]
Professor Greg Fox from the University of Sydney, Australia shared the theme: “Management and treatment of COVID-19 patients, from Australia’s anti-epidemic experience”.
According to him, COVID-19 is an acute respiratory disease caused by a virus, and its manifestations range from asymptomatic to critically ill and cause death. Evidence from clinical trials shows that many interventions can effectively reduce hospitalization and mortality.
Professor Greg Fox said that in Australia, the treatment strategy for people infected with COVID-19 will be selected based on the patient’s severity, prognosis and comorbidities. The clinical chart can guide the doctor to choose the appropriate treatment. The treatment drugs are carefully selected based on published evidence. Treatments that have proven beneficial for some patients include glucocorticoids, Janus kinase inhibitors, IL-6 inhibitors, and antiviral drugs.
According to Professor Greg Fox, some patients may require high-flow nasal oxygen (HFNC) and mechanical ventilation without the use of drugs whose effectiveness has not been proven. The Australian guidelines prioritize these treatments for the most beneficial patients.
Professor Greg Fox concluded: “There are many ways to effectively treat COVID-19. Treatment decisions should be based on evidence and provide specific guidance based on the severity of the disease and the response of the health system.”
Associate Professor Toshie Manabe of Nagoya University in Japan shared the topic “How to successfully control the COVID-19 pandemic-Lessons from Japan”.
Associate Professor Toshie Manabe believes that dealing with emerging infectious diseases requires comprehensive consideration, including epidemiological, clinical and social aspects. Early diagnosis and early treatment are the key to preventing serious forms of emerging infectious diseases. Epidemiological monitoring, stratification and epidemiological investigation, rapid and reasonable deployment of limited health resources, appropriate medical isolation and other measures; educating the community to correctly understand and increase the knowledge of appropriate infection prevention behaviors, including understanding the importance of vaccination …
Dr. Thomas Kesteman from the University of Oxford in the United Kingdom shared strategies for coping with Omicron mutation, which is a highly infectious and avoidable variant of SARS-COV-2. The immune system reduces the protective effect of the vaccine. This mutation may affect COVID-19 control strategies in many countries, including Vietnam.
According to him, more research is needed to evaluate the severity of the Omicron strain and the protective efficacy of the vaccine booster dose against the Omicron strain, in parallel with other non-drug measures. Laboratories and molecular biology laboratories also need to be strengthened and further supported to be able to sequence genes and detect the risk of Omicron mutations entering Vietnam.
Vietnam responds effectively to the epidemic
In Vietnam, Professor Nguyen Gia Binh, chairman of the Vietnam Emergency Resuscitation and Toxic Control Association and the leader of the COVID-19 critically ill treatment group, also reported and shared his experience in “Severe Pathology and Treatment Progress”. cure. “According to Professor Binh, the COVID-19 pandemic first occurred in Wuhan, China in December 2019. Since then, it has spread globally, with more than 270 million infections, more than 5 million deaths, and huge social and economic losses., COVID-19 It leaves long-term consequences that have not been fully assessed.